Gold Nanoparticle-Loaded Biodegradable Polyanhydride Wafers Provide Sustained Gold Availability and Enhance Radiosensitization of Glioblastoma Cells

Glioblastoma is a particularly aggressive form of brain cancer that remains difficult to control even after surgeons remove as much of the tumor as safely possible. Because these cancer cells often spread invisibly into the surrounding healthy brain, radiation therapy is essential to kill the remaining microscopic disease. However, doctors face a delicate balance: they must deliver enough radiation to destroy the cancer without damaging the vital, functioning brain tissue nearby. To make radiation more effective, scientists have looked for ways to make the tumor cells more sensitive to the treatment, a process known as radiosensitization. One promising avenue involves using tiny particles of gold. Gold is a dense metal that interacts strongly with radiation energy, potentially amplifying the damage done to cancer cells when they are hit by a beam. The challenge has been figuring out how to get these particles to stay exactly where they are needed—right at the edge of the surgical cavity where the cancer is most likely to return—without washing away into the rest of the body or causing harm to healthy tissue.

A team of researchers at Shandong University and Shandong First Medical University has developed a new way to keep these gold particles in place using a small, dissolvable wafer. They created a tiny disc made from a biodegradable polymer, a type of plastic that naturally breaks down inside the body over time. They mixed gold nanoparticles, which are particles so small they are measured in billionths of a meter, directly into this polymer before pressing it into a solid disc. The goal was to create an implant that could be placed directly into the space left after tumor removal, slowly releasing the gold particles over weeks while the disc itself dissolved. This approach aims to provide a steady, local supply of gold to sensitize the remaining cancer cells to radiation, rather than relying on a single dose or a system that circulates through the entire body.

The researchers first had to prove that they could successfully make these discs without destroying the gold or the polymer. They mixed the gold particles with the polymer powder and compressed them into discs about the size of a small coin. Using powerful microscopes and chemical analysis, they confirmed that the gold was evenly distributed throughout the disc and that the polymer structure remained intact. They measured the amount of gold in the discs and found that they contained roughly 77 micrograms of gold for every milligram of the disc material, with a high success rate in getting the gold into the final product. They also tested how the discs behaved in a liquid that mimics the body's environment. Over the course of 28 days, the discs slowly lost mass as the polymer broke down, and the gold particles were released into the surrounding liquid. By the 14th day, about half of the gold originally in the disc had been released, and by the end of the experiment, nearly all of the gold could be accounted for, showing that the material was behaving predictably and safely.

Next, the team tested whether these discs could actually help kill cancer cells when combined with radiation. They used a common type of glioblastoma cell line grown in a laboratory dish. To ensure a fair test, they compared four different scenarios: radiation alone, radiation with a blank disc (containing no gold), radiation with free-floating gold particles in the liquid, and radiation with the gold-loaded discs. The free-floating gold particles were matched to the amount of gold that the discs released in the first 24 hours, ensuring that the cells were exposed to the same amount of gold in both the disc and the free-particle groups. The results showed that the blank disc had almost no effect on the cells by itself. However, when the cells were treated with the gold-loaded discs and then exposed to radiation, they were significantly more likely to die than cells treated with radiation alone or radiation with the blank disc.

The most striking finding was that the gold-loaded discs worked better than the free-floating gold particles, even though the amount of gold was the same. When the cells were hit with a standard dose of radiation, the group treated with the gold-loaded discs had the lowest chance of survival. Specifically, at a radiation dose of 4 units, only about 15 percent of the cells from the gold-loaded disc group survived, compared to about 24 percent for the free-floating gold group. At a higher dose of 6 units, the survival rate for the gold-loaded disc group dropped to just over 5 percent, while the free-floating gold group was slightly higher. The researchers calculated a value called the sensitizer enhancement ratio to measure how much better the treatment worked. The gold-loaded discs achieved a ratio of 1.66, meaning they made the radiation significantly more effective than the free-floating gold, which had a ratio of 1.36. This suggests that the way the gold was delivered from the dissolving disc changed how the cells responded to the radiation, perhaps by keeping the gold in contact with the cells for a longer period or by altering how the cells took up the particles.

To understand why the cells were dying, the researchers looked at the damage inside the cells' DNA. Radiation works by breaking the DNA strands, and cells have a specific marker that lights up when this damage occurs. The team found that cells treated with the gold-loaded discs and radiation showed the highest levels of this damage marker, both one hour and 24 hours after the treatment. This confirmed that the gold-loaded discs were causing more persistent damage to the genetic material of the cancer cells than the other methods. The researchers also checked the safety of the discs on normal brain cells, known as astrocytes. They found that the blank discs were harmless, and while the gold-containing treatments did have some effect on normal cells, the difference in response between the cancer cells and the normal cells suggested a potential window for treatment where the cancer could be targeted more effectively.

While these results are promising, the researchers are careful to note that this study was conducted entirely in a laboratory setting using cells in a dish. The discs were placed above the cells in a special insert so they did not touch the cells directly, simulating how they might release material in the body without being embedded in the tissue. The study proves that the concept works in a controlled environment, but it does not yet show how the discs would behave inside a living human or an animal model. The researchers acknowledge that future work needs to determine exactly how the gold particles look after they are released, how they move inside the body, and whether they can safely and effectively treat tumors in a living organism. They also need to test the discs with radiation given in multiple smaller doses over time, which is how patients actually receive treatment, rather than a single large dose.

The study concludes that these gold-loaded, biodegradable wafers are a viable way to deliver gold nanoparticles locally and sustainably. They successfully combined the gold into the material, ensured it was released over time, and demonstrated that this specific method of delivery made radiation therapy more effective against glioblastoma cells in the lab. The findings offer a proof of concept for a new type of implant that could one day help surgeons and oncologists fight the recurrence of this difficult cancer. However, before this technology can be used in patients, it must pass through further stages of testing to confirm its safety and effectiveness in complex living systems. The path forward involves refining the material, understanding exactly how the gold interacts with cells, and validating the results in models that more closely resemble the human brain.